Bristol-Myers Squibb Foundation & Corporate Philanthropy

Sustainability Through Innovation – 2004-2005 Corporate Social Responsibility. A printable version (3.6 MB PDF) is available through the link in the right hand column. Click here to request a printed copy.

Creating A Legacy of Hope – Corporate Social Responsibility At Bristol-Myers Squibb 2003/2004 Report (2.4 MB PDF)

Bristol-Myers Squibb 2003 Sustainability Report

Social Responsibility at Bristol-Myers Squibb (2002)

Report of Charitable Contributions

2001 Grant Recipients
2000 - An Uncommon Effort For The Common Good - Corporate Philanthropy For Change In A Challenging World
1999 - Reaching Out To Women And Children
1998 - Extending and Enhancing Human Life
1997 - Twenty Years Of Unrestricted Support For Biomedical Research

The Fellowship Program In Academic Medicine For Minority Students

2003 Report

SECURE THE FUTURE ™

Newsletter Volume 7 (PDF)
HIV Research Grantee Newsletter Volume 1 (PDF)
Community Outreach And Education Fund Grantee Newsletter Volume 1 (PDF)
Newsletter Volume 5 (PDF)
Newsletter Volume 4 (PDF)
Newsletter Volume 3 (PDF)
Newsletter Volume 2 (PDF)
Newsletter Volume 1 (PDF)

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

Sustainability Through Innovation -- 2004-2005 Corporate Social Responsibility (3.6 MB PDF)